CVS Group earnings 'in line' with guidance as it awaits CMA outcome

  • CVS Group (AIM:CVSG) reported adjusted EBITDA of approximately £134 million for the year ended 30 June 2025, in line with market consensus, according to a trading update released on Thursday. The veterinary services provider said revenue from continuing operations rose 5.4% to £673.2 million, with like-for-like sales up 0.2%.